or Try an Advanced Search...

    Technical Analysis for MRNA - Moderna, Inc.

    Grade Last Price % Change Price Change
    B 107.97 1.69% 1.79
    MRNA closed up 1.69 percent on Friday, April 26, 2024, on 59 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
    Earnings due: May 2
    *** please verify all earnings dates ***
    77 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Up Up
    Historical MRNA trend table...
    Date Alert Name Type % Chg
    Bollinger Band Squeeze Range Contraction 0.00%
    NR7 Range Contraction 0.00%
    Inside Day Range Contraction 0.00%
    20 DMA Support Bullish 1.69%
    Bollinger Band Squeeze Range Contraction 1.69%
    Gapped Down Weakness 1.69%
    MACD Bullish Signal Line Cross Bullish -0.81%
    Bollinger Band Squeeze Range Contraction -0.81%
    Multiple of Ten Bearish Other -0.81%
    BB Squeeze + Upper Band Touch Range Contraction -0.81%
    Older End-of-Day Signals for MRNA ...

       Recent Intraday Alerts

    Alert Time
    Possible NR7 about 14 hours ago
    Possible Inside Day about 14 hours ago
    Up 1% about 18 hours ago
    60 Minute Opening Range Breakdown 1 day ago
    Fell Below 10 DMA 1 day ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    MRNA Chart by TradingView
    Basic chart:

    Profile

    Moderna, Inc. develops medicines based on messenger RNA (mRNA). Its pipeline includes development candidates for mRNA-based vaccines and therapies for use in various therapeutic areas comprising prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: S&P 500 Cancer Life Sciences Biology Nasdaq 100 Vaccines Coronavirus RNA Cancer Vaccine Messenger RNA

    Is MRNA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 26 Moderna (MRNA) Surpasses Market Returns: Some Facts Worth Knowing
    Apr 26 Arvinas, Inc. (ARVN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
    Apr 26 Should You Buy Moderna Before May 12?
    Apr 25 What's Going On With Pfizer Stock On Thursday?
    Apr 25 Analysts Estimate Moderna (MRNA) to Report a Decline in Earnings: What to Look Out for
    Apr 25 UPDATE 3-GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology
    Apr 25 Moderna To Present Respiratory & Cytomegalovirus Research at the ESCMID Global Congress
    Apr 24 Moderna and OpenAI in pact to fast-track drug development
    Apr 24 Moderna turns to AI to change how its employees work
    Apr 24 Moderna and OpenAI Collaborate To Advance mRNA Medicine
    See more MRNA news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 142.79
    52 Week Low 62.65
    Average Volume 3,766,361
    200-Day Moving Average 98.61
    50-Day Moving Average 102.23
    20-Day Moving Average 105.07
    10-Day Moving Average 104.99
    Average True Range 4.60
    RSI (14) 55.75
    ADX 14.91
    +DI 24.37
    -DI 19.39
    Chandelier Exit (Long, 3 ATRs) 102.10
    Chandelier Exit (Short, 3 ATRs) 110.79
    Upper Bollinger Bands 110.39
    Lower Bollinger Band 99.75
    Percent B (%b) 0.77
    BandWidth 10.13
    MACD Line 0.94
    MACD Signal Line 0.80
    MACD Histogram 0.1393
    Fundamentals Value
    Market Cap 41.17 Billion
    Num Shares 381 Million
    EPS -9.23
    Price-to-Earnings (P/E) Ratio -11.70
    Price-to-Sales 3.91
    Price-to-Book 2.48
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 112.16
    Resistance 3 (R3) 111.77 109.98 111.46
    Resistance 2 (R2) 109.98 108.91 110.17 111.23
    Resistance 1 (R1) 108.97 108.25 109.47 109.37 111.00
    Pivot Point 107.18 107.18 107.43 107.38 107.18
    Support 1 (S1) 106.18 106.11 106.68 106.57 104.94
    Support 2 (S2) 104.39 105.45 104.58 104.71
    Support 3 (S3) 103.38 104.39 104.48
    Support 4 (S4) 103.78